Concepedia

Marlon R. Veldwijk

MR

Statistics

Publications

45

Citations

1.7K

H-Index

23

Active since

1997

Affiliations

Heidelberg University(Current)

University Medical Centre Mannheim

German Cancer Research Center

University Hospital Heidelberg

Paracelsus-Kliniken

Marlon R. Veldwijk is an author at Heidelberg University specializing in medicine, radiation oncology, and cell biology.

ORCID

Top concepts

Publications per year

1997–2022

45

Publications

45

Aminoferrocene-Based Prodrugs Activated by Reactive Oxygen Species

Helen Hagen, Paul Marzenell, Elmar Jentzsch et al. · Journal of Medicinal Chemistry · 2011 · 251 citations

, , +14

A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study

Stefan Früehauf, Marlon R. Veldwijk, Timon Seeger et al. · Cytotherapy · 2009 · 123 citations

, , +10

Development and Optimization of a Real-Time Quantitative PCR-Based Method for the Titration of AAV-2 Vector Stocks

Marlon R. Veldwijk, Julian Topaly, Stephanie Laufs et al. · Molecular Therapy · 2002 · 108 citations · Full text

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Petra Seibold, Adam Webb, Miguel E. Aguado‐Barrera et al. · Radiotherapy and Oncology · 2019 · 94 citations · Full text

Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL – Inhibition of P-glycoprotein function by 17-AAG

Aleksandar Radujkovic, M Schad, Julian Topaly et al. · Leukemia · 2005 · 92 citations

, , +7

Rows per page

1–5 of 45